12/12/2017 - 08:00 StockMarketWire
finnCap today initiates coverage of ImmuPharma PLC (LON:IMM) with a buy investment rating and price target of 237p...
28/11/2017 - 12:00 RNS
RNS Number: 7454X Immupharma PLC 28 November 2017 28 November 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Holding(s) in Company ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, has received notification from Alto Invest ("Alto") that Alto now holds 5,242,536 ordinary shares of 10p each in the...
24/11/2017 - 13:32 RNS
RNS Number: 4907X Immupharma PLC 24 November 2017 24 NOVEMBER 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Grant of Options ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces the approval of the grant of options over a total of 7,875,000 ordinar...
02/11/2017 - 09:07 StockMarketWire
ImmuPharma is on track to report top line results from its 52-week, randomised, double-blinded, phase III clinical trial of ...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment